- Home
- ARWR vs CXW Comparison
ARWR vs CXW Comparison
Compare ARWR & CXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- CXW
- Stock Information
- Founded
- ARWR 2003
- CXW 1983
- Country
- ARWR United States
- CXW United States
- Employees
- ARWR N/A
- CXW N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- CXW Real Estate Investment Trusts
- Sector
- ARWR Health Care
- CXW Real Estate
- Exchange
- ARWR Nasdaq
- CXW Nasdaq
- Market Cap
- ARWR 2.4B
- CXW 2.4B
- IPO Year
- ARWR 1993
- CXW 1997
- Fundamental
- Price
- ARWR $19.56
- CXW $23.00
- Analyst Decision
- ARWR Buy
- CXW Buy
- Analyst Count
- ARWR 11
- CXW 3
- Target Price
- ARWR $43.33
- CXW $24.67
- AVG Volume (30 Days)
- ARWR 1.5M
- CXW 1.0M
- Earning Date
- ARWR 02-04-2025
- CXW 02-05-2025
- Dividend Yield
- ARWR N/A
- CXW N/A
- EPS Growth
- ARWR N/A
- CXW 17.92
- EPS
- ARWR N/A
- CXW 0.67
- Revenue
- ARWR $3,551,000.00
- CXW $1,973,599,000.00
- Revenue This Year
- ARWR $3,402.96
- CXW $3.71
- Revenue Next Year
- ARWR $123.96
- CXW $3.15
- P/E Ratio
- ARWR N/A
- CXW $34.33
- Revenue Growth
- ARWR N/A
- CXW 5.16
- 52 Week Low
- ARWR $17.05
- CXW $10.74
- 52 Week High
- ARWR $36.72
- CXW $24.99
- Technical
- Relative Strength Index (RSI)
- ARWR 47.89
- CXW 62.50
- Support Level
- ARWR $17.75
- CXW $21.30
- Resistance Level
- ARWR $19.19
- CXW $23.45
- Average True Range (ATR)
- ARWR 1.04
- CXW 0.85
- MACD
- ARWR 0.04
- CXW 0.04
- Stochastic Oscillator
- ARWR 59.74
- CXW 77.87
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About CXW CoreCivic Inc.
CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.